logo

Alnylam Pharmaceuticals Inc. (ALNY)



Trade ALNY now with
  Date
  Headline
4/13/2020 7:34:59 AM Blackstone To Provide Up To $2 Bln To Support Alnylam's Advancement Of RNA Interference Medicines
4/7/2020 7:05:26 AM Alnylam Pharma Submits Marketing Authorization Application To EMA For Lumasiran For Primary Hyperoxaluria Type 1
4/6/2020 7:08:39 AM Alnylam, Dicerna Form Collaboration On Investigational RNAi Therapeutics For Treatment Of Alpha-1 Liver Disease
3/4/2020 7:04:06 AM Vir, Alnylam Expand Collaboration To Advance RNAi Therapeutics For Coronavirus Infection, Incl COVID-19
3/3/2020 7:03:12 AM Alnylam Announces Approval Of GIVLAARI In European Union For Acute Hepatic Porphyria In Adults And Adolescents
2/27/2020 4:04:44 PM Alnylam Adds Olivier Brandicourt To Its Board
2/26/2020 8:06:39 AM Alnylam Reports Approval In Brazil Of ONPATTRO For Treatment Of Hereditary ATTR Amyloidosis With Polyneuropathy
2/18/2020 7:02:25 AM Alnylam Completes Enrollment Of HELIOS-A Phase 3 Study Of Vutrisiran For HATTR Amyloidosis With Polyneuropathy
2/6/2020 8:08:17 AM Alnylam Pharma Q4 Loss Per Share $2.47 Vs Loss $2.09 Last Year